Cargando…
Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage
OBJECTIVES: Serum neurofilament light chain (NfL) is a biomarker for neuroaxonal damage, and S100B is a blood marker for cerebral damage. In the present study, we investigated the relationship between serum NfL and S100B levels, severity, and outcomes in patients with aneurysmal subarachnoid hemorrh...
Autores principales: | Zhou, Zhangming, Zeng, Junyi, Yu, Shui, Zhao, Ying, Yang, Xiaoyi, Zhou, Yiren, Liang, Qingle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381989/ https://www.ncbi.nlm.nih.gov/pubmed/35989914 http://dx.doi.org/10.3389/fneur.2022.956043 |
Ejemplares similares
-
Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
por: Herrera-Rivero, Marisol, et al.
Publicado: (2023) -
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019) -
The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage
por: Cai, Lingxin, et al.
Publicado: (2021) -
Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022) -
Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case–Control study
por: Stascheit, Frauke, et al.
Publicado: (2023)